Multiple independent work reported that SHP2 regulates the maintenance of CSCs in various tissues [30, 63, 66–68], and the enrichment of stemness is often related to drug resistance of lung cancer [69, 70]. The gene discussed is PTPN11; the disease is lung cancer.